Dreyfus Research Growth ZDREQX

Morningstar Rating

Fund Research and Analysis

by Ryan Leggio

We could back Dreyfus Research Growth if it were available at a better price.

Morningstar research has determined that low expenses are one of the best predictors of good future returns. With that research in mind, this fund should give investors pause. Read more

Kudos

Strong research team.

Decent results since the fund changed in 2005. Read more

Risks

Analysts' team track record here is relatively short.

The A (front-load) share class is one of the most expensive in the category. Read more

Strategy

This fund became a best-ideas portfolio in late 2005. Under this framework, the fund helps measure the success of Dreyfus and The Boston Company's new core research team. As an outlet for the analysts' highest-conviction ideas, only stocks sporting a "buy" rating can be held in the portfolio. Read more

Management

Elizabeth Slover, director of equity research, oversees the effort here, but a central group of 26 analysts drives the stock-picking. Read more

Inside Scoop

This fund has become an analyst-run vehicle. The structure makes its sector weightings roughly mirror the Russell 1000 Growth Index. Then the firm's nearly two dozen analysts are charged with using stock-picking to drive outperformance. Read more

First Name

Last Name

Email Address

Zip Code

Create Password

Verify Password

(6-15 characters; case sensitive)

What is your occupation or job title?

Select...

Your registration indicates agreement to the terms of use.

Picking Positions in Health Care
Watch more